InvestorsHub Logo
Followers 4
Posts 870
Boards Moderated 0
Alias Born 07/19/2020

Re: None

Saturday, 04/10/2021 4:32:16 AM

Saturday, April 10, 2021 4:32:16 AM

Post# of 40503
November 20 2020....INOVIO Presents Results Of Its DNA Medicines INO 5401 +INO 9012 In Novel Combination With PD-1 Inhibitor Libtayo (cemiplimab) in The Treatment Of Newly Diagnosed Glioblastoma Multiforme At The Society For Neuro Oncology 2020 Annual Meeting.....The Presenter Dr David Reardon Clinical Director Of The Center For Neuro Oncology At Dana Farber Cancer Institute.....Dr David Reardon Is A Harvard Trained Doctor And A Strong Advocate For INOVIO And Their Work Regarding Treating Glioblastoma/Brain Cancer.....INOVIO's Partnered With Regeneron's Libtayo.....PRESTIGE ALL THE WAY.....Dr. David Reardon is tops!!!!.....GOOGLE Dr. David Reardon INOVIO INO 5401 And You Will See Numerous Articles And Videos.....GODSPEED INOVIO !!!!!!!!!!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INO News